Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Please explain whether asthma attacks worsened after taking Serevent and whether they required hospitalization or intubation:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Serevent Side Effects Lawsuits | Side Effects: Severe, Life-Threatening, Asthma Episodes, Asthma-Related Deaths

Serevent Side Effects Linked To Asthma-Related Death Lawsuits

Serevent | Lawyer, Lawsuit | Side Effects:  Life-Threatening, Asthma Episodes, Asthma-Related Deaths

David Graham, the FDA researcher who questioned Vioxx's safety before it was recalled has recently raised safety concerns about Serevent. Recently a warning was added to Serevent concerning asthma-related fatalities in studies. Data from a large placebo-controlled US study that compared the safety of Serevent (Generic: Salmeterol) and a placebo showed an increase in asthma-related deaths in patients receiving Serevent. In patients taking Serevent there were 13 deaths out of 13,176. In patients taking the placebo there were only 3 of 13,179.

An older study showed 36 patients taking Serevent died from asthma or had life-threatening attacks. Some patients taking Serevent have had trouble breathing and required intubations, the insertion of a tube into the throat forcing open the airways. Serevent is an aerosol spray. Patients usually use it twice a day to prevent asthma attacks.

Serevent Label Update

The label for Serevent has been updated with a warning stating that the drug can increase the chance of severe asthma attacks that can result in death. The Food & Drug Administration (FDA) made this announcement on May 16, 2006.

Legal Help For Victims Affected By Serevent

If you or a loved one took Serevent and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).


SereventRSS Feed

Warnings for Long-Acting Asthma Drugs Take Effect

Jun 3, 2010 | Parker Waichman LLP
New warnings for the inhaled asthma drugs Advair, Serevent, Foradil and Symbicort have been finalized by the U.S. Food & Drug Administration (FDA). The new warnings were requested by the agency in February, but according to Reuters, the FDA had to exercise new powers to order the changes on Advair and Serevent, both marketed by GlaxoSmithKline, as well as AstraZeneca’s Symbicort. All of these drugs are known as long-acting beta agonists (LABAs). LABAs prevent the release of substances...

FDA Seeks to Limit Use of Serevent, Advair, Symbicort and Foradil

Feb 19, 2010 | Parker Waichman LLP
U.S. regulators want to limit the use of Serevent, Advair, Symbicort and Foradil.  The four drugs, part of a class of asthma medications known as long-acting beta agonists (LABAs), are being subjected to new restrictions, the U.S. Food & Drug Administration (FDA) has announced. These drugs are approved to treat both people with asthma or with chronic obstructive pulmonary disease (COPD). The new recommendations announced by the FDA only apply to the use of LABAs in the treatment of...

FDA Panel Wants Restrictions on Two Asthma Drugs

Dec 12, 2008 | Parker Waichman LLP
A U.S. Food and Drug Administration (FDA) panel has called for restrictions on two asthma treatments:  Serevent and Foradil.  Both belong to a class  of drugs known as long-acting beta-agonists.  Both contain a drug that relaxes muscles around airways, said WHEC TV, but may also mask symptoms that can prompt deadly asthma attacks.  Although the expert 27-member panel found Serevent and Foradil drugs present greater risks than benefits and should not be used in the...

FDA Considers Heart Risks of Serevent, Foradil, Advair and Symbicort

Dec 11, 2008 | Parker Waichman LLP
One expert estimates that long-acting beta-agonists (LABAs)  - a class of asthma drugs that includes Serevent, Foradil, Advair, and Symbicort - might be responsible for about 14,000 deaths, Reuters is reporting.  The comments were part of a confrontational meeting between the U.S. Food and Drug Administration (FDA) and an advisory panel discussing how to handle increased risks experienced with the inhaled asthma medications called LABAs, said Reuters, LABAs are used by millions of...

Complications, Deaths Seen with Some Long-Acting Asthma Drugs

Dec 5, 2008 | Parker Waichman LLP
Some asthma drugs in a class  known as long-acting beta agonists (LABA) can increase the risk of death and complications, a new Food & Drug Administration (FDA) analysis has found.  The analysis looked at GlaxoSmithKline PLC's Serevent and Advair, Novartis AG's and Schering-Plough Corp.'s Foradil and AstraZeneca PLC's Symbicort.The FDA analysis was prepared for an advisory committee meeting next week that is slated to discuss the safety of the drugs, The Wall Street Journal...

More Serevent News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo